| 000 | 01731 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517015240.0 | ||
| 264 | 0 | _c20160531 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a1475-6374 | ||
| 024 | 7 |
_a10.3109/14756366.2014.971780 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aÇıkla-Süzgün, Pelin | |
| 245 | 0 | 0 |
_aAnti-cancer and anti-hepatitis C virus NS5B polymerase activity of etodolac 1,2,4-triazoles. _h[electronic resource] |
| 260 |
_bJournal of enzyme inhibition and medicinal chemistry _c2015 |
||
| 300 |
_a778-85 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aAntiviral Agents _xchemical synthesis |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xchemical synthesis |
| 650 | 0 | 4 |
_aEtodolac _xanalogs & derivatives |
| 650 | 0 | 4 |
_aHepacivirus _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTriazoles _xchemical synthesis |
| 650 | 0 | 4 |
_aViral Nonstructural Proteins _xantagonists & inhibitors |
| 700 | 1 | _aKaushik-Basu, Neerja | |
| 700 | 1 | _aBasu, Amartya | |
| 700 | 1 | _aArora, Payal | |
| 700 | 1 | _aTalele, Tanaji T | |
| 700 | 1 | _aDurmaz, Irem | |
| 700 | 1 | _aÇetin-Atalay, Rengül | |
| 700 | 1 | _aKüçükgüzel, Ş Güniz | |
| 773 | 0 |
_tJournal of enzyme inhibition and medicinal chemistry _gvol. 30 _gno. 5 _gp. 778-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/14756366.2014.971780 _zAvailable from publisher's website |
| 999 |
_c24618162 _d24618162 |
||